We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
General practice pharmacist-led antipsychotic physical health monitoring: a prospective intervention scoping study.
- Authors
Johnson, Chris F; Ingram, Fiona; Thomson, Fiona; Srireddy, Pavan; Jani, Bhautesh D; Greenlaw, Nicola
- Abstract
Background People with severe mental health illness die prematurely, often due to preventable cardiometabolic disease, which can be exacerbated by antipsychotic medicines that are effective for treating mental illness. Literature demonstrates that physical health monitoring, as recommended in guidelines, for people receiving antipsychotics is substandard. Therefore, we aimed to scope the potential of a general practice clinical pharmacist (GPCP)-led multidisciplinary intervention optimising adherence to cardiometabolic monitoring guidelines and delivering polypharmacy reviews. Method Prospective intervention scoping study in three urban general practices; one usual care, two intervention. Patients 18–65 years old prescribed oral antipsychotics were identified from records, and invited for cardiometabolic monitoring and GPCP medication review, from January to December 2022. Interventions and onward referrals were recorded and collated. Anonymised pre- and post-review data were analysed, and actions were graded for clinical importance. Results In total 1.5% (210/14,159) of patients aged 18–65 years met inclusion criteria; usual care practice (n = 58); and intervention practices (n = 152). From baseline, the usual care practice achieved an absolute 7% increase in the cardiometabolic monitoring care bundle (glucose/glycosylated haemoglobin, lipids, blood pressure plus body mass index) versus 19–58% in the intervention practices. Two-thirds (92/152) of patients participated in medication reviews, requiring pharmacological and/or non-pharmacological clinical actions. The majority of actions were graded as moderate importance. Seven percentage of patients were identified as new pre-diabetic/diabetic and 6% were at high risk of cardiovascular disease requiring statin initiation. Conclusion A pharmacist-led multidisciplinary general practice-based approach may be effective at optimising cardiometabolic monitoring; identifying and treating diabetic and cardiovascular risk factors.
- Subjects
MEDICATION reconciliation; CARDIOVASCULAR diseases risk factors; BODY mass index; HEART metabolism disorders; BLOOD pressure
- Publication
Family Practice, 2024, Vol 41, Issue 1, p41
- ISSN
0263-2136
- Publication type
Article
- DOI
10.1093/fampra/cmad120